Regenerative medicine symposium hosted by ISSCA in Buenos Aires, Argentina Aug. 24, 2018, exceeds expectations organizers report
Organizers of the ISSCA regenerative medicine symposium “Applications of Cell Therapies in Medicine and Aesthetic Surgery” held in Buenos Aires, Argentina Aug. 24, 2018, featured 16 physicians traveling from six countries— Mexico, Chile, Colombia, Spain, Costa RIca and the U.S. —to serve as guest speakers.
MIAMI, Aug. 30, 2018—Enthused by the extraordinary success of the International Association for Stem Cell Applications (ISSCA)’s regenerative medicine symposium held at Universidad de Buenos Aires in Argentina Aug. 24, 2018, ISSCA organizers have already begun discussing plans to host the next conference in Miami in summer, 2019.
The 5th annual “Applications of Cell Therapies in Medicine and Aesthetic Surgery,” hosted 250 attendees and featured more than 16 speakers from six countries to discuss the latest clinical stem cell applications for a variety of therapies and treatments including traumatic injuries, pain management, neurological conditions, sports injuries, heart failure, erectile effusion, and aesthetic medicine procedures.
The symposium provided attendees with an opportunity to learn about the most important clinical applications of stem cell therapies from experienced regenerative medicine practitioners.
Leonardo Tacus, M.D., an arthroscopic surgeon specializing in orthopedics, traumatology, and regenerative medicine, spoke to attendees about clinical applications of regenerative medicine therapies to treat injuries sustained by professional athletes.
Jose Benitez, Medical Director of Boston Médical Group Spain. who specializes in male sexual dysfunctions. spoke about stem cell applications used to treat erectile dysfunction.
Calling the symposium their most successful regenerative medicine event to date, iSSCA members and conference speakers held an informative Q&A session lasting three hours until all questions were answered. The session covered a variety of compelling topics regarding stem cell therapies. A lecture based on the symposium will soon be available on ISSCA’s YouTube channel.
Information on the summer, 2019 symposium will be made available in upcoming weeks. For more information, visit stemcellconference.org website, email info@stemcellsgroup.com, or call +1305 560 5337.
About ISSCA:
International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made to the specialty of regenerative medicine.
The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training. and certification.
As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.
###
regenerative medicine symposium Buenos Aires
- Published in Press Releases
ISSCA to sponsor International Congress on Advanced Therapies in Medicine in Riviera Nayarit, Mexico Nov. 24-25, 2018
ISSCA will sponsor the 6th annual International Congress on Advanced Therapies in Medicine Nov. 24-25, 2018 in Riviera Nayarit.
MIAMI, July 27, 2018—For the third consecutive year the International Association for Stem Cell Application (ISSCA) will sponsor the International Congress on Advanced Therapies in Medicine 2018 on Puerto Vallarta, Mexico.
The event will feature a commercial expo with 20 with 20 booths exhibiting new products and information for physicians in the field of regenerative medicine. More than 250 physicians are expected to be in attendance.
ISSCA will present information on its Fellowship in Cell Therapy and Tissue Engineering program, a 6-day course during which a group of experienced academicians involved in stem cell transplantation present the general principles and practice of stem cell biology and evidence-based treatments to physicians looking to optimize the treatment options that benefit the health of their patients. The fellowship program will be held in Korea Oct. 22-27, 2018.
Fellowship participants will take part in a detailed program offering hands-on experience in stem cell applications and learn cell culture protocols including plating, trypsinization, harvesting, and cryopreservation, as well as an understanding and application of quality control tests including cell count, viability, flow cytometry, endotoxin, mycoplasma and sterility.
In addition, physicians participating in the ISSCA fellowship program will learn how to perform cGMP functions including cleanroom maintenance, gowning and environmental monitoring, while gaining insight on relevant applications of stem cell processing and regulations in a certified facility. ISSCA provides fellowship attendees with the tools necessary to implement regulatory and clinical guidelines when setting up a GMP facility, as well as copies of presentations, procedural protocols and all forms associated with a GMP facility provided.
Participating physicians learn to perform clinical procedures including lipoaspirate and bone marrow isolation, and reintroducing stem cells for various indications. Case books and full protocols for approximately 30 indications are also provided.
In addition, Global Stem Cells Group )GSCG) will present its stem cell processing center, a complete solution for providers to equip their practice facilities with an on-site regenerative medicine lab. Used for tissue processing, isolation, culturing and cryopreservation of stem cells, the stem cell processing center is designed to execute a state-of-the-art stem cell laboratory using the latest technology.
GSCG provides participating regenerative medicine teams with specialized training to implement high-level processes and therapies using the stem cell processing center for better clinical interpretation, better results while maintaining compliance with safety regulations and international standards.
GSCG’s stem cell laboratory solution represents a tremendous competitive advantage and differentiator that arms regenerative medicine practitioners with the ability to perform highly advanced stem cell procedures in their facilities.
The 2018 International Congress on Advanced Therapies in Medicine in Riviera Nayarit, Mexico will be held at the Hotel Krystal Grand in Nuevo Puerto Vallarta,
For more information and to register, email info@stemcellsgroup.com, or call +1305 560 5337.
About ISSCA:
The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine.
ISSCA serves its members through advancements made in the specialty of regenerative medicine.ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification.
As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.
About Global Stem Cells Group:
Global Stem Cells Group (GSCG) is a worldwide network that combines seven
major medical corporations. Each corporation is focused on furthering scientific and technological advancements in cutting-edge stem cell research, development, treatment, and training. The united efforts of GSCG’s affiliate companies provide medical practitioners with a one-stopepicenter for stem cell solutions that adhere to the highest medical standards.
Global stem cell’s mission is to be the largest recognized stem cell and regenerative medicine network in the world.
advanced therapies international congress
- Published in Press Releases
ISSCA to sponsor First Congress of Aesthetic Medicine in Asuncion, Paraguay Sept. 20-22, 2018
ISSCA will sponsor the First Congress of Aesthetic Medicine in Paraguay. Featured topics include stem cell applications and digital marketing strategies in aesthetic practices.
MIAMI, July 27, 2018—The International Society for Stem Cell Application (ISSCA) will sponsor the First Congress of Aesthetic Medicine in Asuncion, Paraguay Sept. 20-22, 2018.
The 3-day event will include the latest applications for stem cell therapies in aesthetic medicine.
Dra Silvina Pastrana, medical director of ISSCA affiliate Global Stem Cells Group’s (GSCG) Stem Cell Center in Buenos Aires, Argentina, will be the featured speaker.
Pastrana will discuss the role of stem cell applications in iatrogenic scar healing and share a clinical case involving stem cell therapies used to treat an iatrogenic scar patient.
Benito Novas, a global entrepreneur and medical marketing strategist in the fields of biotechnology, life sciences, and healthcare development, will speak to conference attendees about critical marketing strategies for recruiting aesthetic patients in the digital era.
Novas, Global Stem Cells Group CEO and ISSCA Director of Public Relations, will share digital marketing tactics designed to help aesthetic practices engage new patients.
Novas will discuss the latest tools for managing an aesthetic practice marketing campaign that incorporates social media, content marketing, influencer marketing and other strategies for successfully promoting physician practices.
“Consumers spend no less than three hours per day on social media, which makes it a valuable tool for attracting patients,” Novas says. “Physicians and medical practice administrators attending the conference will learn strategies for leveraging the power of online resources like Twitter, Facebook, and Instagram to reach target audiences, boost leads and effectively recruit new patients.”
Content marketing and other strategies presented at the conference will help aesthetic practices maximize opportunities to attract potential patients by enhancing online visibility while increasing engagement with target audiences.
The First Conference of Aesthetic Medicine in Paraguay will offer a host of regenerative medicine product information and educational activities for aesthetic practitioners.
The event will be held at the Hotel Excelsior in Asuncion, Paraguay To learn more and to register for the conference, visit the First Congress of Aesthetic Medicine website, visit the ISSCA website, email info@stemcellsgroup.com or call 305-560-5337.
About ISSA:|
The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made in the specialty of regenerative medicine.
ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine
As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.
About Global Stem Cells Group:
Global Stem Cells Group (GSCG) is a worldwide network that combines seven major medical corporations. Each corporation is focused on furthering scientific and technological advancements in cutting-edge stem cell research, development, treatment, and training. The united efforts of GSCG’s affiliate companies provide medical practitioners with a one-stop epicenter for stem cell solutions that adhere to the highest medical standards.
Global stem cell’s mission is to be the largest recognized stem cell and regenerative medicine network in the world.
Paraguay aesthetic medicine congress
- Published in Press Releases
ISSCA announces fellowship in cell therapy and tissue engineering
As part of its ongoing efforts to meet growing demand among physicians for continuing education opportunities in advanced cell therapies and tissue banking, the International Society for Stem Cell Application (ISSCA) will hold its next Cell Therapy and Tissue Engineering Fellowship program in Seoul, Korea October 22 – 27, 2018.
ISSCA’s fellowship training program offers physicians an opportunity to build knowledge and increase their therapeutic skills by learning to employ new developments in tissue banking practices and advanced cellular therapies to utilize in their practices.
The fellowship training will enable participating physicians to improve their core skills and competencies in regenerative medicine, establish optimal protocols, policies, and practices in tissue, cell, and advanced therapies, and ultimately enable them to deliver superior services to their patients.
Participating physicians will have the advantage of active engagement with world-class cellular and tissue banking experts in an immersive, hands-on experience while learning theoretical and analytic methods. Fellowship mentors are seasoned professionals devoted to creating new medical technologies and laboratory applications in one of the most rapidly-growing areas of biomedical engineering.
Cell therapy and tissue engineering offer tremendous potential for a career as a practitioner or researcher. Today’s students can be tomorrow’s pioneers in improving the efficacy of medical treatments and advancing the healthcare industry.
Engineering human tissues and organs can provide new treatments and cures for diseases, including blood vessels, bone, cartilage, liver, pancreas, peripheral nerves, and skin cells. Cell therapies and tissue engineering have the potential to revolutionize disease remediation and tissue repair in miraculous ways.
Fellowship participants will have complete access to ISSCA’s accredited stem cell advanced lab protocols. The ISSCA Fellowship program is a 6-day program that offers a certificate of completion issued by ISSCA and Westminster International University in Seoul. Students who complete the fellowship become members of the ISSCA’s international network of regenerative medical professionals and standard setters, with access to events, resources, training, and support moving forward.
ISSCA is the only organization that provides a complete cell therapy and tissue engineering fellowship focused on regenerative medicine. It is also the only fellowship of its kind supported by Korean Universities.
To learn more about the ISSCA fellowship and to reserve a spot at the October 2018 program in Korea, visit the Fellowship in Cell Therapy and Tissue Engineering website, email info@stemcellsgroup.com, or call +1 813 510 9403
About ISSCA:
The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made in the specialty of regenerative medicine.
The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification.
As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.
###
cell therapy fellowship
- Published in Press Releases
ISSCA introduces new stem cell training courses web page for regenerative medicine practitioners
ISSCA has launched a new stem cell training web page designed to offer free information and resources to help physicians choose a training program best suited to their unique needs.
MIAMI, June 26, 2018—The International Society for Stem Cell Application (ISSCA) has launched a new stem cell training course web page, coordinated by Global Stem Cells Group affiliate Stem Cell Training, designed to help physicians access free information and resources on the newest instruction and training options in regenerative medicine training.
The new web page is designed to help physicians interested in adding stem cell procedures to grow their medical practice or enhance career advancement opportunities find stem cell training program options to enable them to find a training program best suited to their individual needs. ISSCA’s variety of stem cell training opportunities include:
• Online stem cell training course, ISSCA’s cutting-edge online course that teaches physicians everything they need to know to add adult stem cell-based procedures to their existing practice, or confidently transition to a regenerative medicine center. Offering the convenience of training from a home or office computer, this course prepares physicians in all the theoretical and practical knowledge needed to effectively and expertly administer stem cell therapies to patients, including harvesting and isolating stem cells.
ISSCA’s online training positions physicians to open their own stem cell center practice and join ISSCA’s expansive network. Successful completion of the online training course allows physicians to immediately begin offering cutting-edge regenerative medicine procedures to patients, establish themselves as experts in their fields, and enjoy the benefits of the growing regenerative medicine industry.
• Hands-on stem cell certification training courses, ISCCA’s intensive, two-day hands-on training course scheduled at various international locations provides attending physicians with expert instruction on autologous stem cell therapies in the field of regenerative medicine. Participants learn techniques and protocols for harvesting and isolating stem and regenerative cells from adipose tissue, bone marrow, and /or peripheral blood from live patients and administering the cells back to the patient
Course curriculum consists of comprehensive theoretical lectures and home study education, and two days of didactic and clinical experience. One day of post-educational on-site clinical assistance is also available upon request.
• Onsite training, ISSCA’s personalized, hands-on, onsite stem cell training brings stem cell specialists to your practice or clinic, anywhere in the world, to provide one-on-one training tailored to your practice’s specific requirements—saving time and money. The onsite training program offers participants a unique opportunity to grow their practice and achieve their specific practice goals by offering practice-specific regenerative medicine treatments to patients in their medical office or clinical setting.
The onsite training course provides participating practices with personalized theoretical information and hands-on training along with ongoing support for their clinical practice. Applications and protocols are provided by a Stem Cells Training faculty member with extensive experience in laboratory and clinical practice.
ISSCA’s onsite training specifications include:
1. Equipment and supply delivery. The Stem Cell Training team
delivers and sets up all equipment and supplies necessary for the training session to take place and will leave the physician’s team
fully qualified to start its own stem cell treatment practice.
2. Expert trainers. ISSCA’s onsite stem cell training course takes a highly visual and interactive approach. Expert trainers teach and supervise the hands-on process using live patients and different protocols for the extraction, isolation, and application of PRP, adipose- and bone marrow-derived stem cells.
3. Multimedia access. ISSCA provides physicians participating in its onsite training program access to its library of high-resolution, step-by-step procedure videos and ongoing online and telephone support for clinical equipment, inquiries or concerns for the practice’s future use and reference.
• Fellowship in cell therapy and tissue engineering. Recognizing the need for knowledge of stem cell protocols among physicians and healthcare professionals, ISSCA and Stem Cell Training created the Fellowship of Stem Cell Therapy and Tissue Engineering program. The fellowship focuses on stem cell therapies involving the potential replacement of cells or organs that are diseased, injured, infirmed, ailing or aged
In this modular training program, a group of experienced academic scholars involved in stem cell transplantation present a series of topics covering the general principles and practices of stem cell
biology and evidence-based treatments that physicians can apply to optimize the health of their patients. Fellowship course details and objectives include:
• A detailed program offering hands-on experience in stem cell characterization and laboratory applications
• An opportunity to learn cell culture processes including plating, trypsinization, harvesting, and cryopreservation
• Gaining the ability to understand and apply quality control tests including cell count, viability, flow cytometry, endotoxin, mycoplasma, and sterility
• Learning to perform CGMP functions including clean room maintenance, gowning, and environmental monitoring
• Establishing insight on relevant applications of stem cell processing and regulations that apply to a certified facility
• Receiving the tools necessary to implement regulatory and clinical guidelines when setting up a GMP facility
• Providing participants with copies of presentations, procedural protocols, and all forms associated with a GMP facility, as well as case books and full protocols for approximately 30 indications
• Demonstrating the ability to perform clinical procedures including lipoaspirate and bone marrow isolation, and reintroduction of stem cells for various indications
The new ISSCA stem cell training web page also features an informative blog that publishes four new articles in the field of regenerative medicine weekly.
To learn more, visit the ISSCA stem cell training web page, email info@stemcellsgroup.com, or call 305-560-5337.
About ISSCA:
The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made in the specialty of regenerative medicine.
The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification.
As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally. Incorporated under the Republic of Korea as a non-profit entity, ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.
Stem cell training web page launch
- Published in Press Releases
Which Works Better, Viscosupplementation, or Platelet Rich Plasma?
Introduction to Viscosupplementation
One of the treatments approved by the FDA for knee arthritis is Hyaluronic Acid (HA) injection, commonly known as viscosupplementation. This treatment has shown significant success in managing knee arthritis and is increasingly being explored for other parts of the body, such as the hip and shoulder, although these uses are not FDA-approved. HA injections mimic the fluid that naturally surrounds your joints, acting as a lubricant and shock absorber, thereby reducing arthritis pain. Over time, HA is absorbed into the joint, potentially stimulating the body to produce more stable cartilage.
Evidence Supporting Viscosupplementation
The evidence supporting HA injections is robust. A systematic review of 76 randomized controlled trials concluded that HA injections can improve function, reduce pain, and serve as a reliable treatment for knee osteoarthritis.
The Role of Platelet-Rich Plasma (PRP) in Treating Arthritis
What is Platelet-Rich Plasma (PRP)?
Platelet-Rich Plasma (PRP) is a concentrate of platelets in plasma, containing 6 to 10 times more platelets than normal blood. PRP is rich in growth factors, such as Epidermal Growth Factor (EGF) and Connective Tissue Growth Factor (CTGF), which promote healing by leveraging the body’s natural healing mechanisms.
FDA Regulation and Research on PRP
Unlike HA, PRP is not FDA-regulated, and the devices used to prepare PRP are subject to FDA approval. Despite this, numerous studies have demonstrated PRP’s efficacy in treating tendon injuries and osteoarthritis, as well as in reducing pain. Ongoing research is exploring its potential benefits for hair regrowth, cardiac muscle repair, and dermatologic rejuvenation.
Comparing HA Injections and PRP
Effectiveness and Safety
Studies indicate that PRP can be just as effective, if not more so, than HA injections. While HA is FDA-approved only for knee use, PRP is derived from the patient’s own blood, reducing the risk of infection and autoimmune reactions, thanks to the presence of white blood cells that help fight infections.
Cost Considerations
HA injections for joints other than the knee are not FDA-approved or typically covered by insurance, often costing patients $1500 or more, excluding additional charges like doctor visits and the injection itself. In contrast, PRP treatments generally cost between $800 and $1200 out of pocket.
Conclusion: Which is the Better Choice?
PRP has demonstrated comparable or superior effectiveness to HA injections for arthritis pain management. It carries a lower risk of infection or autoimmune reactions and is generally more cost-effective. Given these advantages, PRP often emerges as the preferred choice for many patients and healthcare providers.
- Published in Corporate News / Blog
ISSCA to conduct second stem cell certification training course in Lima, Peru
ISSCA to conduct a second hands-on regenerative medicine certification training course in Lima, Peru, Peru August 31, 2018.
MIAMI, June 7, 2018—In response to the success of a recent stem cell certification course in Lima, Peru, the International Society for Stem Cell Application (ISSCA) has announced plans to hold a second stem cell certification training course for qualified physicians in Lima on August 31, 2018.
ISSCA, the only stem cells organization able to travel around the world to teach stem cell harvesting protocols to physicians, conducted the first course in Lima in May. Eight Peruvian physicians were provided highly personalized, hands-on training in harvesting and isolating adipose- and bone marrow-derived stem cells from four live patients under the guidance of stem cell training experts.
Each participating physician obtains the intellectual property of 22 proprietary protocols that will them to treat degenerative and aesthetic diseases and conditions in their offices. Step-by-step videos of each protocol are provided to physicians for later referral.
Participating physicians acquire the skills necessary to offer an alternative therapy to patients with medical conditions for which no solution is currently available. ISSCA’s stem cell training course allows qualified physicians who earn certification to offer sought-after alternative treatments.
Successful completion of the ISSCA regenerative medicine certification course allows physicians to join a select group of practitioners at the forefront of medical science. Only 5 percent of physicians worldwide access to stem cell therapy studies, and so far only 0.01 percent are practicing these therapies.
The course also provides participating physicians with access to ISSCA’s online stem cell training course to review all content and procedures introduced during the two-day clinical training course, as well as patient forms and guidelines, procedures, informed consent forms, didactic lectures, training booklets, and more,
The ISSCA’s regenerative medicine protocols training course was developed for physicians and high-level practitioners to learn techniques in harvesting and reintegrating stem cells derived from patients’ adipose tissue and bone marrow.
Seating is limited to eight participants. Register today at the Lima Peru course website to secure a seat, email info@stemcellsgroup.com, or call 305-560-5337.
About ISSCA:
The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made in the specialty of regenerative medicine.
The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification.
As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.
Stem cell training Lima Peru
- Published in Press Releases
ISSCA to conduct regenerative medicine training course in 3 international cities
ISSCA to conduct hands-on regenerative medicine certification training courses in Mexico City, Bogota, Colombia, and Quito, Ecuador in June 2018.
MIAMI, June 7, 2018—The International Society for Stem Cell Application (ISSCA), the only stem cells organization able to travel around the world to teach stem cell harvesting protocols to physicians, has announced plans to conduct an intensive, hands-on, two-day regenerative medicine certification training course for physicians in three international cities:
Bogota, Colombia: June 8 – 9, 2018.
Quito, Ecuador: June 15 – 16, 2018
Mexico City: June 29 – 30, 2018
Participating physicians will benefit from 20 years of research and development consolidated into the 2-day, intensive, hands-on course. Participants receive highly personalized training on how to harvest and isolate adipose and bone marrow stem cells from live patients under the direction of stem cell training experts. These protocols are important tools for treating patients with degenerative illnesses.
The course also provides participating physicians with access to ISSCA’s online stem cell training course to review all content and procedures introduced during the two-day clinical training course, as well as patient forms and guidelines, procedures, informed consent forms, didactic lectures, training booklets, and more.
The ISSCA’s regenerative medicine protocols training course was developed for physicians and high-level practitioners to learn techniques in harvesting and reintegrating stem cells derived from patients’ adipose tissue and bone marrow.
Seating for all three city’s training courses is limited to eight physicians. Register today at Bogota, Colombia course, Quito, Ecuador course, or Mexico City course, email info@stemcellsgroup.com, or call 305-560-5337.
About ISSCA:
The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made in the specialty of regenerative medicine.
The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification.
As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.
- Published in Press Releases
ISSCA to conduct hands-on regenerative medicine training course at its Abu Dhabi Stem Cell Center
ISSCA will conduct a hands-on regenerative medicine certification training course for physicians at its Stem Cell Center in Abu Dhabi July 8, 2018.
MIAMI, June 7, 2018—In an effort to consolidate its presence in the Middle East and focus on providing the best instruction to new regenerative medicine practitioners, the International Society for Stem Cell Application (ISSCA) has announced plans to conduct a hands-on regenerative medicine certification training course for physicians at its Stem Cell Center in Abu Dhabi July 8, 2018.
The intensive, hands-on training course teaches participating physicians how to harvest stem cells from adipose and bone marrow tissue. Qualified physicians will learn as they conduct regenerative medicine protocols on live patients under the direction of stem cell training experts. Skills learned in the training course can be used in the physician’s practice to treat patients and for career advancement opportunities.
The course also provides participating physicians with access to ISSCA’s online stem cell training course to review all content and procedures introduced during the two-day clinical training course, as well as patient forms and guidelines, procedures, informed consent forms, didactic lectures, training booklets, and more.
The ISSCA’s regenerative medicine protocols training course was developed for physicians and high-level practitioners to learn techniques in harvesting and reintegrating stem cells derived from patients’ adipose tissue and bone marrow.
The July 8, 2018, regenerative medicine training course will be held at the ISSCA Stem Cell Center in Abu Dhabi.
Seating for this training course is limited. Register today to participate by visiting the Stem Cell Training Abu Dhabi website, email info@stemcellsgroup.com, or call 305-560-5337.
About ISSCA:
The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made to the specialty of regenerative medicine.
The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification.
As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.
Stem cell training Abu Dhabi
- Published in Press Releases
Platelet-Rich Plasma Stays Quietly Popular Despite Neglect
Fact: PRP Treatments Are Highly In-Demand
According to research, PRP treatments are one of the most in-demand treatments available in healthcare. This is impressive considering the following challenges PRP faces:
- Lack of Support from the Medical Industry: PRP is not backed by big pharma, meaning no extensive research or marketing is funded.
- Absence of Lobbying by Medical Associations: There are no medical associations working to increase awareness of PRP.
- No Insurance Reimbursements: Insurance companies do not reimburse PRP treatments, making it difficult to get patients to pay for a treatment that is relatively “unproven.”
- Rising Costs: In 2006, a PRP treatment cost $450. Today, it costs $800, with the cheapest being $650.
Despite these obstacles, the demand for PRP treatments remains robust.
The Future of PRP
We believe the best of PRP is yet to come. A breakthrough study could propel PRP into mainstream hospitals and clinics. The most significant growth in PRP is currently happening in Asia, rooted in fundamental healing theory.
The Healing Power of PRP
The growth of PRP can be attributed to its fundamental healing properties:
- Increased Platelets: More platelets mean more growth factors and cytokines, leading to enhanced healing.
- Natural Healing Mechanism: Our body’s natural healing mechanism operates with 150,000/ul-350,000/ul platelets in blood. Using PRP amplifies this number by 3X to 5X, translating to better healing.
Platelet-Rich Plasma Trends
PRP can be used to promote the healing of injured tendons, ligaments, muscles, and joints, and is applied to various musculoskeletal problems. Regular studies test its effectiveness. One landmark study involved double-blind randomized controlled trials to see the effect of PRP on patients with chronic low back pain caused by torn discs. The study found that 60% of the patients felt significant improvements, with some even being cured.
Platelet-Rich Plasma Variants
There are several types of PRP variants:
- Plasma Rich in Growth Factors (PRGF)
- Plasma Rich in Platelets and Growth Factors (PRPGF)
- Platelet-Rich Plasma (PRP)
- Platelet Poor Plasma (PPP)
- Plasma Rich in Platelets and Rich in Leukocytes (LR-PRP)
- Plasma Rich in Platelets and Poor in Leukocytes (LP-PRP)
- Platelet-Rich Fibrin Matrix (PRFM)
All of them involve plasmapheresis—the two-stage centrifugation process to separate platelets from blood. The industry has yet to standardize which variant to use, but we believe the confusion will clear up in 3-5 years.
Bio-Factors at Play in PRP
Regardless of the PRP variant used, the following bio-factors are at play:
- Growth Factors: TGF-B, PDGF, IGF-I,II, FGF, EGF, VEGF, ECGF
- Adhesive Proteins: Fibrinogen, Fibronectin, Vitronectin, Thrombospondin-1
- Clotting & Anti-Clotting Factors: Proteins, Antithrombin, Plasminogen, Proteases, Antiproteases
How Platelet-Rich Plasma Actually Works
PRP is commonly used for wound healing and pain management because platelets aid coagulation, act as a biological glue, and support stem or primary cell migration. They also help restore hyaluronic acid, accelerate collagen synthesis, and increase cartilage matrix.
Platelets delivered in a clot can immediately act as a scaffold to enable the healing process. 95% of bio-active proteins are released within 1 hour of injecting PRP, and platelets continue to release growth factors for 7-10 days. Thus, it’s recommended to re-inject PRP every 7 days.
Why Patients Choose PRP Despite the Cost
Patients are willing to pay out of pocket for PRP treatments despite insurance companies not covering it because:
- Effectiveness: The treatment works.
- Natural and Side-Effect-Free: There is nothing else as natural and side-effect-free as PRP.
PRP for Osteoarthritis
Consider osteoarthritis, which affects 27 million Americans. When doctors started doing PRP treatments for their osteoarthritis patients, a large majority experienced no further cartilage loss. This suggests PRP should be the default first-line treatment for osteoarthritis across the country.
PRP for Hair Loss and Cosmetic Applications
PRP also has significant potential in treating hair loss and cosmetic facial applications. Studies have shown reduced hair loss and increased hair density, with patients expressing high satisfaction levels.
The Growing PRP Market
The PRP market is expected to hit $126 million in 2016, a 180% increase over the 2009 figure of $45 million. For osteoarthritis alone, if all 27 million Americans received 1 PRP shot a year at a conservative $400 per treatment, it would be a $10 billion market.
PRP for Tennis Elbow
PRP is also known to work well for Tennis Elbow, which affects 1% to 3% of the overall population and up to 50% of tennis players.
Insurance Coverage for PRP
Getting PRP covered by insurance could significantly expand the market and help heal millions of patients more naturally and effectively. It could also save insurance companies money by reducing the need for more expensive interventions like surgery.
Challenges and the Future of PRP
The vast scope of PRP treatment calls for urgent structure and guidelines. There are some 20+ conditions where researchers have found it helpful. Proving its efficiency in all these areas is a daunting task, but we will get there with enough funding and standardized procedures.
Conclusion
Despite being classified as “unproven,” PRP has vast potential. With the right number of platelets, platelet activation, and cytokine release, PRP can consistently deliver positive outcomes. Although there is still uncertainty over the number of injections, timing, and delivery method, widespread adoption will eventually lead to a more structured approach.
Let’s hope the first glimpses of this structure will arrive soon. In 2015, the world saw approximately 1 million knee arthroplasties for osteoarthritis, costing $25 billion. How many of these patients could have benefited from PRP early on?
- Published in Corporate News / Blog
